Farwell Wildon 4
4 · Dyne Therapeutics, Inc. · Filed Feb 28, 2024
Insider Transaction Report
Form 4
Farwell Wildon
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-02-28$25.00/sh−407$10,175→ 163,096 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 14, 2023.
- [F2]Includes 140,510 unvested RSUs.